Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Bergstrom

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Clinical Pharmacology|May 1, 1985
Single-dose and steady-state pharmacokinetics of tomoxetine in normal subjectsN A Farid, R F Bergstrom, E A Ziege, et al.
Clinical Pharmacology and Therapeutics|November 1, 1987
Absorption studies of the H2-blocker nizatidineM P Knadler, R F Bergstrom, J T Callaghan, et al.
Clinical Pharmacology and Therapeutics|April 1, 1990
Relationship between steady-state plasma nizatidine concentrations and inhibition of basal and stimulated gastric acid secretionD W Schneck, J T Callaghan, R F Bergstrom, et al.
Clinical Pharmacology and Therapeutics|June 1, 1988
Nizatidine disposition in subjects with normal and impaired renal functionG R Aronoff, R F Bergstrom, R J Bopp, et al.
Clinical Pharmacology and Therapeutics|February 1, 1985
Intravenous nizatidine kinetics and acid suppressionJ T Callaghan, R F Bergstrom, B D Obermeyer, et al.
European Journal of Clinical Pharmacology|January 1, 1979
Plasma protein binding of prednisolone in normal volunteers and arthritic patientsI T Ağabeyoğlu, R F Bergstrom, W R Gillespie, et al.
Clinical Pharmacology and Therapeutics|June 1, 1990
Secretion of nizatidine into human breast milk after single and multiple dosesB D Obermeyer, R F Bergstrom, J T Callaghan, et al.
The Journal of Laboratory and Clinical Medicine|April 1, 1981
Plasma protein-binding parameters of prednisolone in immune disease patients receiving long-term prednisone therapyJ G Wagner, D Wexler, I T Ağabeyoğlu, et al.
Clinical Pharmacology and Therapeutics|July 1, 1984
Fluoxetine kinetics and protein binding in normal and impaired renal functionG R Aronoff, R F Bergstrom, S T Pottratz, et al.
Pharmacotherapy|December 17, 1998
Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy menW L Macias, R F Bergstrom, B J Cerimele, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Clinical Pharmacology|May 1, 1985
Single-dose and steady-state pharmacokinetics of tomoxetine in normal subjectsN A Farid, R F Bergstrom, E A Ziege, et al.
Clinical Pharmacology and Therapeutics|November 1, 1987
Absorption studies of the H2-blocker nizatidineM P Knadler, R F Bergstrom, J T Callaghan, et al.
Clinical Pharmacology and Therapeutics|April 1, 1990
Relationship between steady-state plasma nizatidine concentrations and inhibition of basal and stimulated gastric acid secretionD W Schneck, J T Callaghan, R F Bergstrom, et al.
Clinical Pharmacology and Therapeutics|June 1, 1988
Nizatidine disposition in subjects with normal and impaired renal functionG R Aronoff, R F Bergstrom, R J Bopp, et al.
Clinical Pharmacology and Therapeutics|February 1, 1985
Intravenous nizatidine kinetics and acid suppressionJ T Callaghan, R F Bergstrom, B D Obermeyer, et al.
European Journal of Clinical Pharmacology|January 1, 1979
Plasma protein binding of prednisolone in normal volunteers and arthritic patientsI T Ağabeyoğlu, R F Bergstrom, W R Gillespie, et al.
Clinical Pharmacology and Therapeutics|June 1, 1990
Secretion of nizatidine into human breast milk after single and multiple dosesB D Obermeyer, R F Bergstrom, J T Callaghan, et al.
The Journal of Laboratory and Clinical Medicine|April 1, 1981
Plasma protein-binding parameters of prednisolone in immune disease patients receiving long-term prednisone therapyJ G Wagner, D Wexler, I T Ağabeyoğlu, et al.
Clinical Pharmacology and Therapeutics|July 1, 1984
Fluoxetine kinetics and protein binding in normal and impaired renal functionG R Aronoff, R F Bergstrom, S T Pottratz, et al.
Pharmacotherapy|December 17, 1998
Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy menW L Macias, R F Bergstrom, B J Cerimele, et al.
Pageof 4